Lipotropic Agents

"Lipotropic Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Endogenous factors or drugs that increase the transport and metabolism of LIPIDS including the synthesis of LIPOPROTEINS by the LIVER and their uptake by extrahepatic tissues.

Descriptor ID

D008082

MeSH Number(s)

D27.505.519.186.071.601

D27.505.954.483.680

D27.505.954.557.500.601

Concept/Terms

Below are MeSH descriptors whose meaning is more general than "Lipotropic Agents".

Chemicals and Drugs [D]
Chemical Actions and Uses [D27]
Pharmacologic Actions [D27.505]
Molecular Mechanisms of Pharmacological Action [D27.505.519]
Antimetabolites [D27.505.519.186]
Hypolipidemic Agents [D27.505.519.186.071]
Lipotropic Agents [D27.505.519.186.071.601]
Therapeutic Uses [D27.505.954]
Gastrointestinal Agents [D27.505.954.483]
Lipotropic Agents [D27.505.954.483.680]
Lipid Regulating Agents [D27.505.954.557]
Hypolipidemic Agents [D27.505.954.557.500]
Lipotropic Agents [D27.505.954.557.500.601]

Below are MeSH descriptors whose meaning is related to "Lipotropic Agents".

Below are MeSH descriptors whose meaning is more specific than "Lipotropic Agents".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Lipotropic Agents" by people in Harvard Catalyst Profiles by year, and whether "Lipotropic Agents" was a major or minor topic of these publication.

Bar chart showing 9 publications over 8 distinct years, with a maximum of 2 publications in 2016

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1999	0	1	1
2005	0	1	1
2007	1	0	1
2010	0	1	1
2012	0	1	1
2014	1	0	1
2016	0	2	2
2018	0	1	1

Below are the most recent publications written about "Lipotropic Agents" by people in Profiles.

Defining the Transcriptional Targets of Leptin Reveals a Role for Atf3 in Leptin Action. Diabetes. 2018 06; 67(6):1093-1104.

View in: PubMed
Maternal choline supplementation during murine pregnancy modulates placental markers of inflammation, apoptosis and vascularization in a fetal sex-dependent manner. Placenta. 2017 05; 53:57-65.

View in: PubMed
Nonalcoholic fatty liver disease: Updates on associations with the metabolic syndrome and lipid profile and effects of treatment with PPAR-? agonists. Metabolism. 2017 01; 66:64-68.

View in: PubMed
Enhancing hepatic fibrosis in spontaneously hypertensive rats fed a choline-deficient diet: a follow-up report on long-term effects of oxidative stress in non-alcoholic fatty liver disease. J Hepatobiliary Pancreat Sci. 2016 May; 23(5):260-9.

View in: PubMed
Hepatocyte specific deletion of c-Met leads to the development of severe non-alcoholic steatohepatitis in mice. J Hepatol. 2014 Oct; 61(4):883-90.

View in: PubMed
Fibroblast growth factor 21 and thyroid hormone show mutual regulatory dependency but have independent actions in vivo. Endocrinology. 2014 May; 155(5):2031-40.

View in: PubMed
Nutrient-based therapies for bipolar disorder: a systematic review. Psychother Psychosom. 2013; 82(1):10-9.

View in: PubMed
Double-blind therapeutic trial in Angelman syndrome using betaine and folic acid. Am J Med Genet A. 2010 Aug; 152A(8):1994-2001.

View in: PubMed
Dietary uridine enhances the improvement in learning and memory produced by administering DHA to gerbils. FASEB J. 2008 Nov; 22(11):3938-46.

View in: PubMed
The association between betaine and choline intakes and the plasma concentrations of homocysteine in women. Am J Clin Nutr. 2007 Oct; 86(4):1073-81.

View in: PubMed

Related Networks

People

Explore

Similar Concepts

Top Journals

Placenta
Endocrinology
Boll Soc Ital Biol Sper
Am J Clin Nutr
J Hepatobiliary Pancreat Sci
J Cell Physiol
J Biochem Mol Toxicol
FASEB J
Diabetes
Am J Med Genet A